Quinine Sulfate Market Report 2026

Quinine Sulfate Market Overview

• Quinine Sulfate market size has reached to $2.59 billion in 2025 • Expected to grow to $3.81 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Growing Malaria Incidence Boosts Quinine Sulfate Market Due To Increased Treatment Demand • Asia-Pacific was the largest region in 2025.

What Is Covered Under Quinine Sulfate Market?

Quinine sulfate is a naturally derived alkaloid medication extracted from the bark of the cinchona tree, commonly employed in pharmaceutical formulations for its therapeutic properties. It is primarily used to treat malaria and alleviate nocturnal leg cramps, due to its ability to interfere with the reproduction of malaria-causing parasites and relax muscle contractions. The main types of quinine sulfate are 200 mg, 300 mg, and others. 200 mg of quinine sulfate refers to a dosage of the medication used to treat conditions such as malaria, where each dose contains 200 milligrams of the active ingredient. The product forms include quinine sulfate tablets, quinine sulfate capsules, quinine sulfate injections, quinine sulfate powder, and quinine sulfate oral solutions. These are distributed by various channels, such as hospitals, retail pharmacies, and online pharmacies. It is used in applications such as treating malaria, problematic leg cramps, lupus, rheumatoid arthritis, and others. The end users of quinine sulfate include adults, pediatrics, and geriatrics.

What Is The Quinine Sulfate Market Growth Forecast?

The quinine sulfate market size is expected to see strong growth in the next few years. It will grow to $3.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to ongoing malaria control programs, demand for low-cost antimalarials, expansion of generic manufacturing, improved drug delivery formats, rising healthcare access in developing regions. Major trends in the forecast period include sustained demand for antimalarial therapies, continued use in nocturnal leg cramp treatment, expansion of generic quinine products, growing focus on affordable essential medicines, improved pharmaceutical formulations.

Global Quinine Sulfate Market Segmentation

1) By Type: 200mg, 300mg, Other Types 2) By Product Form: Quinine Sulfate Tablets, Quinine Sulfate Capsules, Quinine Sulfate Injections, Quinine Sulfate Powder, Quinine Sulfate Oral Solutions 3) By Distribution Channel: Hospitals, Retail Pharmacies, Online Pharmacies 4) By Application: Malaria, Problematic Leg Cramps, Lupus, Rheumatoid Arthritis, Other Applications 5) By End-User: Adults, Pediatrics, Geriatrics

What Are The Drivers Of The Quinine Sulfate Market?

The growing malaria incidence is expected to propel the growth of the quinine sulfate market going forward. Malaria is a life-threatening infectious disease caused by Plasmodium parasites transmitted through the bite of infected female Anopheles mosquitoes. The rise in malaria cases is driven by expanding mosquito habitats due to climate change, increasing drug-resistant parasite strains, and gaps in healthcare access. The quinine sulfate market supports malaria treatment by killing Plasmodium parasites and inhibiting their ability to grow and reproduce within red blood cells. For instance, in December 2024, according to the UK Health Security Agency (UKHSA), a UK-based government departments, the annual malaria report for 2023 shows that there were 2,106 cases of imported malaria reported in the UK. This is 26% higher than the cases reported in 2022. Therefore, the growing malaria incidence is driving the growth of the quinine sulfate industry. The increasing interest in natural and organic products is expected to propel the growth of the quinine sulfate market going forward. Natural and organic products refer to goods made from minimally processed, plant-based, or sustainably sourced ingredients without synthetic chemicals or artificial additives. The rising interest in natural and organic products is driven by growing health awareness, demand for chemical-free alternatives, and increasing focus on environmental and ethical sourcing practices. The quinine sulfate market supports this shift by offering a plant-derived compound extracted from cinchona bark, aligning with consumer preferences for traditional herbal ingredients in wellness and medicinal applications. For instance, in May 2024, according to the 2024 Organic Industry Survey published by the Organic Trade Association (OTA), a US-based business association, U.S. certified organic product sales reached $69.7 billion in 2023, reflecting a 3.4% increase from 2022. Therefore, the increasing interest in natural and organic products is driving the growth of the quinine sulfate industry.

Key Players In The Global Quinine Sulfate Market

Major companies operating in the quinine sulfate market are Sanofi SA, Viatris Inc., Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Strides Pharma, Wockhardt Ltd., Pharmakina SA, Alchem International Private Limited, SimSon Pharma Limited, Hangzhou Dayang Co. Ltd., Haihang Industry Co. Ltd., Aecochem Corp, Buchler GmbH, Prism Industries Private Limited, Shreeji Pharma International, Sihauli Chemicals Private Limited

What Are Latest Mergers And Acquisitions In The Quinine Sulfate Market?

In June 2023, AlphaTalents Africa LP, an Africa-based investment company, acquired a controlling stake in Pharmakina for an undisclosed amount. With this acquisition, AlphaTalents Africa LP aims to strengthen local quinine processing and boost the production of affordable anti-malarial medicines in the Democratic Republic of Congo. Pharmakina SA is an Africa-based company that provides the producer and supplier of quinine sulfate.

Regional Insights

Asia-Pacific was the largest region in the quinine sulfate market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Quinine Sulfate Market?

The quinine sulfate market consists of sales of quinine sulfate suspensions, quinine sulfate granules, quinine sulfate infusions, quinine sulfate suppositories, and quinine sulfate topical preparations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Quinine Sulfate Market Report 2026?

The quinine sulfate market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the quinine sulfate industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.